Inflamm-aging of the stem cell niche: Breast cancer as a paradigmatic example

被引:70
作者
Bonafe, Massimiliano [1 ,2 ]
Storci, Gianluca [1 ,2 ,3 ]
Franceschi, Claudio [1 ]
机构
[1] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy
[2] Univ Bologna, Policlin S Orsola Malpighi, Ctr Appl Biomed Res, CRBA, I-40126 Bologna, Italy
[3] Univ Bologna, Policlin S Orsola Malpighi, Inst Oncol & Hematol L&A Seragnoli, I-40126 Bologna, Italy
关键词
ageing; cancer; DNA damage; inflammation; stem cell; stem cell niche; EPITHELIAL-MESENCHYMAL TRANSITION; P53; TUMOR-SUPPRESSOR; KAPPA-B PATHWAY; STROMAL FIBROBLASTS; MAMMARY-GLAND; SELF-RENEWAL; INTERLEUKIN-6; MACROPHAGES; SENESCENCE; GROWTH;
D O I
10.1002/bies.201100104
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflamm-aging is a relatively new terminology used to describe the age-related increase in the systemic pro-inflammatory status of humans. Here, we represent inflamm-aging as a breakdown in the multi-shell cytokine network, in which stem cells and stromal fibroblasts (referred to as the stem cell niche) become pro-inflammatory cytokine over-expressing cells due to the accumulation of DNA damage. Inflamm-aging self-propagates owing to the capability of pro-inflammatory cytokines to ignite the DNA-damage response in other cells surrounding DNA-damaged cells. Macrophages, the major cellular player in inflamm-aging, amplify the phenomenon, by broadcasting pro-inflammatory signals at both local and systemic levels. On the basis of this, we propose that inflamm-aging is a major contributor to the increase in cancer incidence and progression in aged people. Breast cancer will be presented as a paradigmatic example for this relationship.
引用
收藏
页码:40 / 49
页数:10
相关论文
共 99 条
[51]  
Herbert BS, 2010, ONCOTARGET, V1, P405
[52]   Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells [J].
Hernandez-Vargas, Hector ;
Ouzounova, Maria ;
Le Calvez-Kelm, Florence ;
Lambert, Marie-Pierre ;
McKay-Chopin, Sandrine ;
Tavtigian, Sean V. ;
Puisieux, Alain ;
Matar, Chantal ;
Herceg, Zdenko .
EPIGENETICS, 2011, 6 (04) :429-440
[53]   Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation [J].
Hodge, DR ;
Peng, B ;
Cherry, JC ;
Hurt, EM ;
Fox, SD ;
Kelley, JA ;
Munroe, DJ ;
Farrar, WL .
CANCER RESEARCH, 2005, 65 (11) :4673-4682
[54]   Mutations in Bone Marrow-Derived Stromal Stem Cells Unmask Latent Malignancy [J].
Houghton, JeanMarie ;
Li, Hanchen ;
Fan, Xueli ;
Liu, Yingwang ;
Liu, Jian Hua ;
Rao, Varada P. ;
Poutahidis, Theofilos ;
Taylor, Christie L. ;
Jackson, Erin A. ;
Hewes, Christine ;
Lyle, Stephen ;
Cerny, Anna ;
Bowen, Glennice ;
Cerny, Jan ;
Moore, Nathan ;
Kurt-Jones, Evelyn A. ;
Erdman, Susan E. .
STEM CELLS AND DEVELOPMENT, 2010, 19 (08) :1153-1166
[55]   Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion [J].
Iliopoulos, Dimitrios ;
Hirsch, Heather A. ;
Wang, Guannan ;
Struhl, Kevin .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (04) :1397-1402
[56]   An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation [J].
Iliopoulos, Dimitrios ;
Hirsch, Heather A. ;
Struhl, Kevin .
CELL, 2009, 139 (04) :693-706
[57]   Radiation-induced bystander signaling pathways in human fibroblasts: A role for interleukin-33 in the signal transmission [J].
Ivanov, Vladimir N. ;
Zhou, Hongning ;
Ghandhi, Shanaz A. ;
Karasic, Thomas B. ;
Yaghoubian, Benjamin ;
Amundson, Sally A. ;
Hei, Tom K. .
CELLULAR SIGNALLING, 2010, 22 (07) :1076-1087
[58]   Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling [J].
Jones, Simon A. ;
Scheller, Juergen ;
Rose-John, Stefan .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09) :3375-3383
[59]   Fibroblasts in cancer [J].
Kalluri, R ;
Zeisberg, M .
NATURE REVIEWS CANCER, 2006, 6 (05) :392-401
[60]   Identification of human papillomavirus DNA gene sequences in human breast cancer [J].
Kan, CY ;
Iacopetta, BJ ;
Lawson, JS ;
Whitaker, NJ .
BRITISH JOURNAL OF CANCER, 2005, 93 (08) :946-948